These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26576761)

  • 21. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
    Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
    Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of HPV vaccination: a FIGO statement.
    Denny L;
    Int J Gynaecol Obstet; 2013 Dec; 123(3):187-8. PubMed ID: 24139200
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and perception: What are the greatest enemies of HPV vaccination programmes?
    Bonanni P; Zanella B; Santomauro F; Lorini C; Bechini A; Boccalini S
    Vaccine; 2018 Aug; 36(36):5424-5429. PubMed ID: 28610824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysautonomia case report of a variant.
    LINDE LM
    J Pediatr; 1955 Apr; 46(4):453-5. PubMed ID: 14368453
    [No Abstract]   [Full Text] [Related]  

  • 25. Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination.
    Blitshteyn S; Brook J
    Immunol Res; 2017 Feb; 65(1):282-284. PubMed ID: 27561785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary prevention of cervical cancer: prophylactic human papillomavirus vaccines.
    Mandic A
    J BUON; 2012; 17(3):422-7. PubMed ID: 23033276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of dysautonomia.
    LINDE LM
    Pediatrics; 1956 Nov; 18(5):692-700. PubMed ID: 13370234
    [No Abstract]   [Full Text] [Related]  

  • 29. Esophageal and gastric abnormalities in dysautonomia.
    LINDE LM; WESTOVER JL
    Pediatrics; 1962 Feb; 29():303-6. PubMed ID: 14465409
    [No Abstract]   [Full Text] [Related]  

  • 30. Postural tachycardia syndrome following human papillomavirus vaccination.
    Blitshteyn S
    Eur J Neurol; 2014; 21(1):135-9. PubMed ID: 24102827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central autonomic dysfunction in multiple system atrophy: can we measure it with MRI?
    van Eimeren T
    Clin Auton Res; 2020 Jun; 30(3):185-187. PubMed ID: 32418031
    [No Abstract]   [Full Text] [Related]  

  • 32. HPV 6,11,16,18 vaccine: pharmacovigilance reports in 2007.
    Prescrire Int; 2008 Aug; 17(96):160. PubMed ID: 19496245
    [No Abstract]   [Full Text] [Related]  

  • 33. ACP Journal Club: quadrivalent HPV vaccination was not linked to multiple sclerosis or other demyelinating diseases.
    Granwehr B
    Ann Intern Med; 2015 Apr; 162(8):JC13. PubMed ID: 25894046
    [No Abstract]   [Full Text] [Related]  

  • 34. Mandatory HPV vaccination.
    Gilkey MB; Brewer NT
    JAMA; 2012 Jan; 307(3):252-3; author reply 254-5. PubMed ID: 22253386
    [No Abstract]   [Full Text] [Related]  

  • 35. Mandatory HPV vaccination.
    Tomljenovic L; Shaw CA
    JAMA; 2012 Jan; 307(3):254; author reply 254-5. PubMed ID: 22253388
    [No Abstract]   [Full Text] [Related]  

  • 36. Mandatory HPV vaccination.
    Berger LC; Blog D; Birkhead GS
    JAMA; 2012 Jan; 307(3):253-4; author reply 254-5. PubMed ID: 22253387
    [No Abstract]   [Full Text] [Related]  

  • 37. Human papillomavirus vaccines: 2014 safety review.
    Prescrire Int; 2015 May; 24(160):122-5, 128-9. PubMed ID: 26034804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of HPV vaccines in the age of nonavalent vaccination.
    Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL
    Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus vaccine introduction--the first five years.
    Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
    Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus.
    Brinth LS; Pors K; Theibel AC; Mehlsen J
    Vaccine; 2015 May; 33(22):2602-5. PubMed ID: 25882168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.